| Name | IONIS-FB-LRx |
|---|
| Description | IONIS-FB-LRx is a specific antisense oligonucleotide (ASO) targeting complement factor B (CFB). IONIS-FB-LRx effectively reduces circulating levels of CFB. IONIS-FB-LRx can be used for geographic atrophy (GA) research[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Complement factor B (CFB)[1] |
| In Vivo | IONIS-FB-Lrx is administered by subcutaneous injection every four weeks and targets CFB’s hepatic expression[2]. |
| References |
| No Any Chemical & Physical Properties |